Healthcare | March 17, 2025
CKD cases surge to 16.38% in Indians aged 15+
Experts urge early detection & better access to care
Experts urge early detection & better access to care
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
STABILIZE-CKD and DIALIZE-Outcomes trials are part of the CRYSTALIZE evidence programme
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
The Phase IV DREAM-CKD trial will enrol 1004 CKD patients in India, including 502 dialysis dependent, 502 dialysis independent CKD patients with anemia.
AstraZeneca and Indian Society of Nephrology aim to help clinicians and healthcare practitioners to provide holistic kidney care to their patients.
Conceptulised by Lowe Lintas, the new campaign creatively brings the "fast action" benefit of Cipladine to life through a series of films
In Q4 FY25, our pharmaceutical business reported revenue growth of 20% to Rs 351 crore and EBIT growth of 65% to Rs 55 croe, on QoQ basis
Empamore is poised to make a significant impact by offering high-quality treatment at an affordable price point, empowering millions of Indians to take control of their health
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
Subscribe To Our Newsletter & Stay Updated
